Wordt geladen...
Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison
Third-generation tyrosine kinase inhibitors (TKIs) were developed to overcome T790M-mediated resistance to earlier generations of epidermal growth factor receptor (EGFR)-targeted TKIs. We compared four well-established and one in-house method for the analysis of the EGFR T790M mutation in plasma cel...
Bewaard in:
Gepubliceerd in: | Front Oncol |
---|---|
Hoofdauteurs: | , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Frontiers Media S.A.
2019
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6646711/ https://ncbi.nlm.nih.gov/pubmed/31380273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00631 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|